MoonLake Immunotherapeutics CSO Kristian Reich disposes of $1 million in common shares

Reuters2026/07/23 20:06

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

MoonLake Immunotherapeutics Chief Scientific Officer Kristian Reich sold 52,448 Class A ordinary shares on July 21-22.
Sales priced at USD 20.02 per share on 50,000 shares, USD 20 per share on 2,448 shares.
Indirect holdings fell to 2,712,298 shares following the transactions.
Separately, he reported 35,389 shares held directly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moonlake Immunotherapeutics published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-080869), on July 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

MoonLake Immunotherapeutics CSO Kristian Reich disposes of $1 million in common shares

You may also like

Crypto prices